JACQUELINE WAYMAN: Open Payments
NPI 1093394843 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 11 payments from 7 companies in 2025. Trend: 2023 $43 · 2024 $132 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| HARMONY BIOSCIENCES LLC | 1 | $18 |
Products named: VRAYLAR, FANAPT, SPRAVATO, CAPLYTA, Auvelity, REXULTI, WAKIX.
Industry payments across NE — which companies pay providers there.
